Home
/
U S PHYSICAL THERAPY INC /NV
/
Financials
/
Quarterly
U S PHYSICAL THERAPY INC /NV — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that U S PHYSICAL THERAPY INC /NV filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$197.13M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$197.34M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$183.79M
May 9, 2025
Q3
2025
Sep 30, 2024
$168.03M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$167.19M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$155.68M
May 9, 2025
Q3
2024
Sep 30, 2023
$150.01M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$151.49M
Aug 14, 2024
Q1
2024
Mar 31, 2023
$148.51M
May 8, 2024
Q3
2023
Sep 30, 2022
$139.60M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$140.66M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$131.70M
May 5, 2023
Q3
2022
Sep 30, 2021
$125.89M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$126.93M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$112.37M
May 9, 2022
Q3
2021
Sep 30, 2020
$106.93M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$83.86M
Aug 9, 2021
Q1
2021
Mar 31, 2020
$112.72M
May 10, 2021
Q3
2020
Sep 30, 2019
$117.25M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$126.37M
Aug 7, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$197.13M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$197.34M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$183.79M
May 9, 2025
Q3
2025
Sep 30, 2024
$168.03M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$167.19M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$155.68M
May 9, 2025
Q3
2024
Sep 30, 2023
$150.01M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$151.49M
Aug 14, 2024
Q1
2024
Mar 31, 2023
$148.51M
May 8, 2024
Q3
2023
Sep 30, 2022
$139.60M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$140.66M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$131.70M
May 5, 2023
Q3
2022
Sep 30, 2021
$125.89M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$126.93M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$112.37M
May 9, 2022
Q3
2021
Sep 30, 2020
$108.93M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$83.86M
Aug 9, 2021
Q1
2021
Mar 31, 2020
$112.72M
May 10, 2021
Q3
2020
Sep 30, 2019
$117.25M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$126.37M
Aug 7, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$103.03M
Nov 7, 2017
Q2
2017
Jun 30, 2017
$104.25M
Aug 7, 2017
Q1
2017
Mar 31, 2017
$97.57M
Jun 29, 2017
Q3
2017
Sep 30, 2016
$88.34M
Nov 7, 2017
Q2
2017
Jun 30, 2016
$90.43M
Aug 7, 2017
Q1
2017
Mar 31, 2016
$86.91M
Jun 29, 2017
Q3
2016
Sep 30, 2015
$84.05M
Nov 4, 2016
Q2
2016
Jun 30, 2015
$83.29M
Aug 5, 2016
Q1
2016
Mar 31, 2015
$77.24M
May 6, 2016
Q3
2015
Sep 30, 2014
$77.72M
Nov 5, 2015
Q2
2015
Jun 30, 2014
$78.20M
Aug 6, 2015
Q1
2015
Mar 31, 2014
$69.77M
May 7, 2015
Q3
2014
Sep 30, 2013
$65.83M
Nov 7, 2014
Q2
2014
Jun 30, 2013
$66.87M
Aug 7, 2014
Q1
2014
Mar 31, 2013
$62.76M
May 9, 2014
Q3
2013
Sep 30, 2012
$62.10M
Nov 7, 2013
Q2
2013
Jun 30, 2012
$63.96M
Aug 8, 2013
Q1
2013
Mar 31, 2012
$62.58M
May 9, 2013
Q3
2012
Sep 30, 2011
$59.68M
Nov 9, 2012
Q2
2012
Jun 30, 2011
$59.91M
Sep 6, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$13.14M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$12.39M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$9.90M
May 9, 2025
Q3
2025
Sep 30, 2024
$6.63M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$7.51M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$8.05M
May 9, 2025
Q3
2024
Sep 30, 2023
$9.25M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$10.92M
Aug 14, 2024
Q1
2024
Mar 31, 2023
$7.41M
May 8, 2024
Q3
2023
Sep 30, 2022
$9.56M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$11.20M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$8.80M
May 5, 2023
Q3
2022
Sep 30, 2021
$10.01M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$12.44M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$8.17M
May 9, 2022
Q3
2021
Sep 30, 2020
$10.92M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$10.23M
Aug 9, 2021
Q1
2021
Mar 31, 2020
$1.02M
May 10, 2021
Q3
2020
Sep 30, 2019
$9.05M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$14.62M
Aug 7, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$25.33M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$24.94M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$19.64M
May 9, 2025
Q3
2025
Sep 30, 2024
$12.85M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$15.57M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$14.93M
May 9, 2025
Q3
2024
Sep 30, 2023
$15.88M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$20.06M
Aug 14, 2024
Q1
2024
Mar 31, 2023
$17.00M
May 8, 2024
Q3
2023
Sep 30, 2022
$14.90M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$20.08M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$15.03M
May 5, 2023
Q3
2022
Sep 30, 2021
$16.93M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$22.23M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$15.02M
May 9, 2022
Q3
2021
Sep 30, 2020
$19.94M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$10.26M
Aug 9, 2021
Q1
2021
Mar 31, 2020
$4.01M
May 10, 2021
Q3
2020
Sep 30, 2019
$16.82M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$19.90M
Aug 7, 2020